Insider filing · IMVT
Christopher Van Tuyl
Chief Legal Officer
profile →
Immunovant, Inc.
IMVT · Healthcare · 33 filings in 24 months
ticker →
Christopher Van Tuyl sold $683K of Immunovant (IMVT)
Executed Jun 26, disclosed Jun 26, the same day.
Value, as filed
$683K
17,824 sh across 2 lots
Executed
Jun 26
the trade date, as filed
Disclosed
Jun 26
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CTChristopher Van Tuyl (Chief Legal Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Immunovant, Inc. (IMVT). The largest single filing was $683K of IMVT (17,824 sh across 2 lots, as filed), executed Jun 26.
The name
IMVTHealthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Christopher Van Tuyl in IMVT
IMVTSALE
Immunovant, Inc.
$128K5,165 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET IMVTSALE Immunovant, Inc. $228K
8,529 sh × $26.78
Exec Dec 18 2025
Filed Dec 19 2025 · 5:30 PM ET